These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17090288)

  • 21. [Clinical course of inflammatory bowel disease in patients transplanted for primary sclerosing cholangitis].
    Villamil A; De Paula JA; Galdame O; Piccioni H; Ciardullo M; De Santibañes E; Gadano A
    Acta Gastroenterol Latinoam; 2008 Dec; 38(4):252-9. PubMed ID: 19157380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infliximab-induced palmoplantar pustulosis in a patient with crohn disease.
    Sladden MJ; Clarke PJ; Wettenhall J
    Arch Dermatol; 2007 Nov; 143(11):1449. PubMed ID: 18025378
    [No Abstract]   [Full Text] [Related]  

  • 23. Colon cancer after infliximab therapy for Crohn's disease.
    Ferreira F; Lopes S; Macedo G
    BioDrugs; 2010 Dec; 24 Suppl 1():18-21. PubMed ID: 21175230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cautionary tale of biologic therapy.
    Chang LP; Masson J; Mahy G
    Intern Med J; 2009 Dec; 39(12):e2-4. PubMed ID: 20233234
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: Fefferman et al.--"Recurrence" of chronic pancreatitis appearing on a patient with underlying Crohn's disease.
    Triantafillidis JK; Cheracakis P
    Am J Gastroenterol; 2002 Mar; 97(3):761-2. PubMed ID: 11922579
    [No Abstract]   [Full Text] [Related]  

  • 26. Disseminated tuberculosis in a Crohn's disease patient on anti-TNF alpha therapy despite chemoprophylaxis.
    Bourikas LA; Kourbeti IS; Koutsopoulos AV; Koutroubakis IE
    Gut; 2008 Mar; 57(3):425; author reply 425-6. PubMed ID: 18268059
    [No Abstract]   [Full Text] [Related]  

  • 27. Psoriasiform and pustular eruption induced by infliximab.
    Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
    J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of infliximab infusion reactions on long-term outcomes in patients with Crohn's disease.
    Moss AC; Fernandez-Becker N; Jo Kim K; Cury D; Cheifetz AS
    Aliment Pharmacol Ther; 2008 Jul; 28(2):221-7. PubMed ID: 18485127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fulminant acute hepatitis B after infliximab treatment in Crohn's disease].
    Olfa H; Aroua G; Wissem M; Wafa BM; Hichem L; Nabil BC; Fethia B; Leila S
    Tunis Med; 2014 May; 92(5):349-50. PubMed ID: 25504398
    [No Abstract]   [Full Text] [Related]  

  • 30. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
    Hyams J; Crandall W; Kugathasan S; Griffiths A; Olson A; Johanns J; Liu G; Travers S; Heuschkel R; Markowitz J; Cohen S; Winter H; Veereman-Wauters G; Ferry G; Baldassano R;
    Gastroenterology; 2007 Mar; 132(3):863-73; quiz 1165-6. PubMed ID: 17324398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infliximab-induced acne: report of two cases.
    Bassi E; Poli F; Charachon A; Claudepierre P; Revuz J
    Br J Dermatol; 2007 Feb; 156(2):402-3. PubMed ID: 17223901
    [No Abstract]   [Full Text] [Related]  

  • 32. [Development of tuberculosis after treatment with the TNF-alpha inhibitor infliximab].
    Dahl M; Ravn P
    Ugeskr Laeger; 2005 Jan; 167(5):527-8. PubMed ID: 15745179
    [No Abstract]   [Full Text] [Related]  

  • 33. Remicade approved for children with Crohn's disease.
    FDA Consum; 2006; 40(4):6. PubMed ID: 17245830
    [No Abstract]   [Full Text] [Related]  

  • 34. Infliximab induced liver injury in Crohn's disease: a challenging diagnosis.
    Carvalheiro J; Mendes S; Sofia C
    J Crohns Colitis; 2014 May; 8(5):436-7. PubMed ID: 24291019
    [No Abstract]   [Full Text] [Related]  

  • 35. Generalized pustular psoriasis triggered by infliximab in two patients with Crohn's disease.
    Kato Y; Yamamoto T
    J Dermatol; 2013 Nov; 40(11):932-3. PubMed ID: 24127642
    [No Abstract]   [Full Text] [Related]  

  • 36. Does administration of infliximab increase susceptibility to listeriosis?
    Morelli J; Wilson FA
    Am J Gastroenterol; 2000 Mar; 95(3):841-2. PubMed ID: 10710107
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of biologics and other therapies in stricturing Crohn's disease: what have we learnt so far?
    Sorrentino D
    Digestion; 2008; 77(1):38-47. PubMed ID: 18285676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
    de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
    Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated serum IgE prior to acute severe infusion reaction during infliximab maintenance therapy in a Crohn's disease patient.
    Kato S; Kobayashi T; Kani K; Takabayashi H; Yamamoto R; Yakabi K
    Inflamm Bowel Dis; 2011 Dec; 17(12):E156-7. PubMed ID: 21898702
    [No Abstract]   [Full Text] [Related]  

  • 40. Immortal time bias in estimates of mortality among infliximab-treated patients with Crohn's disease.
    Lewis JD
    Gut; 2010 Nov; 59(11):1586-7. PubMed ID: 20732919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.